Jane Street’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PTCT
RI
VPM
VCM
AC
Jane Street's PTCT Position: Q1 2026 in Review
Jane Street sold out of PTC Therapeutics (PTCT) in Q1 2026, closing a stake of 3,925 shares — an estimated $278K sold.
Jane Street first reported a position in PTCT in Q2 2014 and held it in 35 quarters. The position peaked at $22.5M in Q4 2023. 350 funds tracked by Wall St. Rank hold PTCT as of Q1 2026.
- Jane Street reported no remaining PTC Therapeutics position as of Q1 2026 after selling out during the quarter.
- Jane Street sold 3,925 PTC Therapeutics shares in Q1 2026, an estimated $278K.
- Jane Street first reported a position in PTC Therapeutics in Q2 2014 and held it in 35 quarters.
- Jane Street's PTC Therapeutics position peaked at $22.5M in Q4 2023.
- 350 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.